Temsirolimus: all 177 studies that test it
Page 2 of 2. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue SarcomaTerminatedNCT01204450Phase 1
- Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid TumorsCompletedNCT01198184Phase 1
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
- A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid TumorsWithdrawnNCT01182883Phase 1
- Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate CancerTerminatedNCT01174199Phase 1
- Efficacy Study of Temsirolimus to Treat Head and Neck CancerCompletedNCT01172769Phase 2
- Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)WithdrawnNCT01170052Phase 1/2
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid TumorsCompletedNCT01141244Phase 1
- Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)CompletedNCT01122615Phase 1
- Temsirolimus in Myelodysplastic Syndrome (MDS)TerminatedNCT01111448Phase 2
- Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumCompletedNCT01090466Phase 1/2
- Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced CancerActive, not recruitingNCT01087554Phase 1
- Temsirolimus in Treating Patients With Advanced Liver Cancer and CirrhosisTerminatedNCT01079767Phase 2
- Study of Nelfinavir and Temsirolimus in Patients With Advanced CancersCompletedNCT01079286Phase 1
- Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell LymphomaCompletedNCT01078142Phase 1/2
- Temsirolimus and Pazopanib in Patients With Advanced Solid TumorsCompletedNCT01072890Phase 1
- AZD2171 and Temsirolimus in Patients With Advanced Gynecological MalignanciesCompletedNCT01065662Phase 1
- A Study of Temsirolimus Plus Capecitabine in Patients With Advanced CancerCompletedNCT01050985Phase 1
- Perifosine With Temsirolimus for Recurrent Pediatric Solid TumorsCompletedNCT01049841Phase 1
- Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT01019434Phase 2
- Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01015664Phase 1/2
- Temsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT01008917Phase 1
- Study of Temsirolimus, Erlotinib and Cisplatin in Solid TumorsCompletedNCT00998036Phase 1
- Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus SunitinibCompletedNCT00979966Phase 2
- Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral MicrodialysisWithdrawnNCT00949026Phase 1
- Temsirolimus in Recurrent Primary Central Nervous System (CNS) LymphomaStatus unknownNCT00942747Phase 2
- Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only RelapseTerminatedNCT00926107Phase 2
- Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to TreatmentCompletedNCT00909831Phase 1
- Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to TreatmentCompletedNCT00880282Phase 1
- Temsirolimus for Relapsed/Refractory Hodgkin's LymphomaTerminatedNCT00838955Phase 2
- A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma MultiformeCompletedNCT00800917Phase 2
- Temsirolimus and Radiation for Non-Small Cell Lung CancerCompletedNCT00796796Phase 1
- S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid TumorsWithdrawnNCT00788580Phase 1
- Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00787969Phase 1
- A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain TumorsCompletedNCT00784914Phase 1
- Study of Temsirolimus, Topotecan, and BortezomibCompletedNCT00770731Phase 1
- Erlotinib and Temsirolimus for Solid TumorsCompletedNCT00770263Phase 1
- Doxil, Bevacizumab and Temsirolimus TrialCompletedNCT00761644Phase 1
- Phase I Study of Docetaxel and Temsirolimus in Resistant Solid MalignanciesCompletedNCT00703625Phase 1
- Phase I Study of DOXIL and Temsirolimus in Resistant Solid MalignanciesCompletedNCT00703170Phase 1
- Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple MyelomaCompletedNCT00693433Phase 1
- Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00678769Phase 1
- Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or LymphomaCompletedNCT00659568Phase 1
- Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell CarcinomaCompletedNCT00619268Phase 2
- Bevacizumab and Temsirolimus in Patients With Advanced MalignancyCompletedNCT00610493Phase 1
- Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal CancerCompletedNCT00593060Phase 1
- Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic CancerTerminatedNCT00593008Phase 1
- A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic MalignanciesCompletedNCT00523432Phase 1
- Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate CancerTerminatedNCT00512668Phase 1
- Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00408655Phase 1
- Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple MyelomaCompletedNCT00398515Phase 1
- Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaCompletedNCT00349206Phase 1
- Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00316849Phase 1
- Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver FunctionCompletedNCT00275093Phase 1
- Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00255658Phase 1
- An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer PatientsCompletedNCT00235794Not applicable
- Study Evaluating CCI-779 in Relapsing Multiple SclerosisCompletedNCT00228397Phase 2
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00112476Phase 1
- Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNCT00101088Phase 1
- CCI-779 and EKB-569 in Treating Patients With Advanced Solid TumorsCompletedNCT00098501Phase 1
- CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal TumorCompletedNCT00087074Phase 2
- CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaTerminatedNCT00086840Phase 2
- CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic PhaseCompletedNCT00084916Phase 2
- Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast CancerTerminatedNCT00083993Phase 3
- Temsirolimus in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00079456Phase 2
- CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung CancerCompletedNCT00079235Phase 2
- Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate TherapyTerminatedNCT00076206Phase 2
- CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00075647Phase 2
- Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of RelapseCompletedNCT00071968Phase 2
- CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's LymphomaCompletedNCT00033267Phase 2
- CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00028028Phase 2
- CCI-779 in Treating Patients With Malignant GliomaCompletedNCT00022724Phase 1/2
- CCI-779 in Treating Patients With Metastatic MelanomaCompletedNCT00022464Phase 2
- CCI-779 in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00016328Phase 2
- CCI-779 in Treating Patients With Prostate CancerCompletedNCT00012142Phase 2
- CCI-779 in Treating Patients With Advanced Solid TumorsCompletedNCT00003712Phase 1